INFU
InfuSystem Holdings, Inc
Company overview
- Market capitalization
- $259.74M
- Employees
- 461
- Latest publication
- 2026-09-29
About InfuSystem Holdings, Inc
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. It also sells and rents new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, the company offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 36,933,000USD | 33,684,000USD | 36,230,000USD | 36,488,000USD | 36,002,000USD | 34,716,000USD | 33,848,000USD | 35,320,000USD |
| Cost Of Revenue | 15,520,000USD | 14,002,000USD | — | 15,668,000USD | 16,128,000USD | 15,549,000USD | — | 16,275,000USD |
| Gross Profit | 21,413,000USD | 19,682,000USD | 20,435,000USD | 20,820,000USD | 19,874,000USD | 19,167,000USD | 18,216,000USD | 19,045,000USD |
| Selling And Marketing Expenses | 2,989,000USD | 3,080,000USD | — | 2,366,000USD | 2,704,000USD | 2,985,000USD | — | 2,755,000USD |
| General And Administrative Expenses | 14,097,000USD | 14,803,000USD | — | 14,429,000USD | 13,146,000USD | 15,316,000USD | — | 12,777,000USD |
| Other Operating Expenses | 175,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 17,261,000USD | 18,092,000USD | — | 17,009,000USD | 16,097,000USD | 18,549,000USD | — | 15,780,000USD |
| Operating Income | 4,152,000USD | 1,590,000USD | 3,714,000USD | 3,811,000USD | 3,777,000USD | 618,000USD | 2,616,000USD | 3,265,000USD |
| Total Other Income Expense Net | -281,000USD | -173,000USD | — | -384,000USD | -331,000USD | -365,000USD | — | -480,000USD |
| Interest Expense | 255,000USD | 255,000USD | — | 330,000USD | 373,000USD | 336,000USD | — | 476,000USD |
| Income Before Tax | 3,871,000USD | 1,417,000USD | 3,497,000USD | 3,427,000USD | 3,446,000USD | 253,000USD | 2,264,000USD | 2,785,000USD |
| Income Tax Expense | 640,000USD | 400,000USD | 1,461,000USD | 1,168,000USD | 847,000USD | 520,000USD | 1,331,000USD | 978,000USD |
| Net Income | 3,231,000USD | 1,017,000USD | 2,036,000USD | 2,259,000USD | 2,599,000USD | -267,000USD | 933,000USD | 1,807,000USD |
| Selling General Administrative | — | 14,803,000USD | 16,721,000USD | 14,429,000USD | 13,146,000USD | 15,316,000USD | 15,600,000USD | 12,777,000USD |
| Labor And Related Expense | — | 2,478,000USD | — | 4,043,000USD | 4,415,000USD | 4,316,000USD | — | — |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosurePreliminary | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosurePreliminary | DisclosureDeterministicFinal |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 143,436,000USD | 134,861,000USD | 125,785,000USD | 109,914,000USD | 102,382,000USD | 97,388,000USD | 81,115,000USD | 67,138,000USD |
| Cost Of Revenue | 63,140,000USD | 64,458,000USD | 62,676,000USD | 47,343,000USD | 42,185,000USD | 38,629,000USD | 34,233,000USD | 19,332,000USD |
| Gross Profit | 80,296,000USD | 70,403,000USD | 63,109,000USD | 62,571,000USD | 60,197,000USD | 58,759,000USD | 46,882,000USD | 39,018,000USD |
| Selling General Administrative | 56,969,000USD | 51,209,000USD | 45,377,000USD | 46,077,000USD | 42,261,000USD | 35,195,000USD | 29,023,000USD | 24,847,000USD |
| Selling And Marketing Expenses | 10,487,000USD | 11,312,000USD | 12,654,000USD | 12,259,000USD | 10,777,000USD | 9,661,000USD | 9,932,000USD | 9,107,000USD |
| General And Administrative Expenses | 56,969,000USD | 51,209,000USD | 45,377,000USD | 46,077,000USD | 42,261,000USD | 35,195,000USD | 29,023,000USD | 24,847,000USD |
| Total Operating Expenses | 68,376,000USD | 63,512,000USD | 59,021,000USD | 60,917,000USD | 57,377,000USD | 49,932,000USD | 43,357,000USD | 38,603,000USD |
| Operating Income | 11,920,000USD | 6,891,000USD | 4,088,000USD | 1,654,000USD | 2,820,000USD | 8,827,000USD | 3,525,000USD | 415,000USD |
| Total Other Income Expense Net | -1,297,000USD | -1,832,000USD | -2,237,000USD | -1,524,000USD | -1,563,000USD | -1,284,000USD | -2,001,000USD | -1,457,000USD |
| Interest Expense | 1,299,000USD | 1,777,000USD | 2,170,000USD | 1,402,000USD | 1,377,000USD | 1,255,000USD | 1,904,000USD | 1,420,000USD |
| Labor And Related Expense | 16,328,000USD | 18,573,000USD | — | — | — | — | — | — |
| Income Before Tax | 10,623,000USD | 5,059,000USD | 1,851,000USD | 130,000USD | 1,257,000USD | 7,543,000USD | 1,524,000USD | -1,042,000USD |
| Income Tax Expense | 3,996,000USD | 2,714,000USD | 979,000USD | 112,000USD | -163,000USD | -9,789,000USD | 163,000USD | 53,000USD |
| Net Income | 6,627,000USD | 2,345,000USD | 872,000USD | 18,000USD | 1,420,000USD | 17,332,000USD | 1,361,000USD | -1,095,000USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 97,700,000USD | 98,657,000USD | 100,560,000USD | 98,881,000USD | 100,849,000USD | 104,282,000USD | 103,614,000USD | 105,303,000USD |
| Cash And Equivalents | 964,000USD | 2,106,000USD | 3,186,000USD | 955,000USD | 720,000USD | 1,506,000USD | 527,000USD | 380,000USD |
| Total Current Assets | 38,272,000USD | 36,662,000USD | 36,336,000USD | 35,571,000USD | 34,800,000USD | 35,322,000USD | 32,165,000USD | 33,613,000USD |
| Other Current Assets | 4,584,000USD | 4,744,000USD | 4,858,000USD | 4,717,000USD | 3,931,000USD | 3,829,000USD | 3,955,000USD | 3,772,000USD |
| Other Non Current Assets | 1,519,000USD | 1,646,000USD | 1,678,000USD | 499,000USD | 432,000USD | 597,000USD | 878,000USD | 1,009,000USD |
| Total Liabilities | 38,554,000USD | 39,908,000USD | 43,234,000USD | 43,410,000USD | 46,315,000USD | 49,134,000USD | 46,085,000USD | 49,790,000USD |
| Total Current Liabilities | 15,300,000USD | 17,142,000USD | 20,182,000USD | 18,718,000USD | 15,861,000USD | 15,969,000USD | 17,661,000USD | 16,936,000USD |
| Other Current Liabilities | 6,321,000USD | 7,510,000USD | 9,361,000USD | 8,694,000USD | 6,543,000USD | 7,602,000USD | 7,813,000USD | 8,028,000USD |
| Total Stockholder Equity | 59,146,000USD | 58,749,000USD | 57,326,000USD | 55,471,000USD | 54,534,000USD | 55,148,000USD | 57,529,000USD | 55,513,000USD |
| Total Equity Including Noncontrolling Interest | 59,146,000USD | 58,749,000USD | 57,326,000USD | 55,471,000USD | 54,534,000USD | 55,148,000USD | 57,529,000USD | 55,513,000USD |
| Long Term Debt | 20,424,000USD | 19,646,000USD | 19,625,000USD | 20,932,000USD | 26,347,000USD | 28,707,000USD | 23,864,000USD | 27,975,000USD |
| Net Receivables | 27,205,000USD | 23,980,000USD | 22,901,000USD | 24,309,000USD | 24,481,000USD | 23,892,000USD | 21,155,000USD | 22,761,000USD |
| Inventory | 5,519,000USD | 5,832,000USD | 5,391,000USD | 5,590,000USD | 5,668,000USD | 6,095,000USD | 6,528,000USD | 6,700,000USD |
| Property Plant Equipment Net | 6,521,000USD | 7,061,000USD | 7,537,000USD | 8,169,000USD | 8,676,000USD | 9,166,000USD | 9,404,000USD | 9,645,000USD |
| Goodwill | 3,710,000USD | 3,710,000USD | 3,710,000USD | 3,710,000USD | 3,710,000USD | 3,710,000USD | 3,710,000USD | 3,710,000USD |
| Intangible Assets | 6,482,000USD | 6,656,000USD | 6,866,000USD | 7,077,000USD | 7,150,000USD | 6,208,000USD | 6,456,000USD | 6,704,000USD |
| Accounts Payable | 8,979,000USD | 9,632,000USD | 10,821,000USD | 10,024,000USD | 9,318,000USD | 8,367,000USD | 9,848,000USD | 8,908,000USD |
| Common Stock | 2,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD |
| Retained Earnings | -60,812,000USD | -60,541,000USD | -60,702,000USD | -61,432,000USD | -61,523,000USD | -60,622,000USD | -57,460,000USD | -58,194,000USD |
| Accumulated Other Comprehensive Income | 606,000USD | 575,000USD | 565,000USD | 642,000USD | 717,000USD | 870,000USD | 1,119,000USD | 836,000USD |
| Short Long Term Debt | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 100,560,000USD | 103,614,000USD | 102,915,000USD | 99,388,000USD | 97,586,000USD | 96,991,000USD | 79,224,000USD | 64,073,000USD |
| Cash And Equivalents | 3,186,000USD | 527,000USD | 231,000USD | 165,000USD | 186,000USD | 9,648,000USD | 2,647,000USD | 4,318,000USD |
| Total Current Assets | 36,336,000USD | 32,165,000USD | 30,620,000USD | 24,779,000USD | 22,065,000USD | 29,771,000USD | 19,305,000USD | 17,537,000USD |
| Other Current Assets | 4,858,000USD | 3,955,000USD | 4,157,000USD | 2,922,000USD | 2,535,000USD | 2,402,000USD | 1,662,000USD | 1,372,000USD |
| Other Non Current Assets | 1,678,000USD | 878,000USD | 1,581,000USD | 80,000USD | 471,000USD | 105,000USD | 155,000USD | 137,000USD |
| Total Liabilities | 43,234,000USD | 46,085,000USD | 50,613,000USD | 51,385,000USD | 49,314,000USD | 56,239,000USD | 56,890,000USD | 43,632,000USD |
| Total Current Liabilities | 20,182,000USD | 17,661,000USD | 15,713,000USD | 14,467,000USD | 12,896,000USD | 22,997,000USD | 21,847,000USD | 14,790,000USD |
| Other Current Liabilities | 9,361,000USD | 7,813,000USD | 7,704,000USD | 6,126,000USD | 4,685,000USD | 6,795,000USD | 5,803,000USD | 2,763,000USD |
| Total Stockholder Equity | 57,326,000USD | 57,529,000USD | 52,302,000USD | 48,003,000USD | 48,272,000USD | 40,752,000USD | 22,334,000USD | 20,441,000USD |
| Total Equity Including Noncontrolling Interest | 57,326,000USD | 57,529,000USD | 52,302,000USD | 48,003,000USD | 48,272,000USD | 40,752,000USD | 22,334,000USD | 20,441,000USD |
| Short Long Term Debt | 0USD | 0USD | 0USD | 0USD | 698,000USD | 9,423,000USD | 8,082,000USD | 4,903,000USD |
| Long Term Debt | 19,625,000USD | 23,864,000USD | 29,101,000USD | 33,157,000USD | 32,748,000USD | 29,378,000USD | 30,295,000USD | 28,842,000USD |
| Net Receivables | 22,901,000USD | 21,155,000USD | 19,830,000USD | 16,871,000USD | 15,405,000USD | 14,720,000USD | 12,097,000USD | 9,593,000USD |
| Inventory | 5,391,000USD | 6,528,000USD | 6,402,000USD | 4,821,000USD | 3,939,000USD | 3,001,000USD | 2,899,000USD | 2,254,000USD |
| Property Plant Equipment Net | 7,537,000USD | 9,404,000USD | 11,024,000USD | 8,553,000USD | 8,764,000USD | 8,757,000USD | 9,770,000USD | 1,445,000USD |
| Goodwill | 3,710,000USD | 3,710,000USD | 3,710,000USD | 3,710,000USD | 3,710,000USD | — | — | — |
| Intangible Assets | 6,866,000USD | 6,456,000USD | 7,446,000USD | 8,436,000USD | 10,930,000USD | 11,177,000USD | 15,463,000USD | 19,865,000USD |
| Accounts Payable | 10,821,000USD | 9,848,000USD | 8,009,000USD | 8,341,000USD | 7,862,000USD | 6,779,000USD | 7,962,000USD | 7,091,000USD |
| Common Stock | 2,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD |
| Retained Earnings | -60,702,000USD | -57,460,000USD | -58,625,000USD | -59,344,000USD | -53,903,000USD | -44,035,000USD | -61,367,000USD | -62,728,000USD |
| Accumulated Other Comprehensive Income | 565,000USD | 1,119,000USD | 1,088,000USD | 1,489,000USD | 268,000USD | — | — | — |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Depreciation | 3,253,000USD | 3,349,000USD | 3,070,000USD | 3,094,000USD | 3,320,000USD | 3,173,000USD | 2,897,000USD | 2,786,000USD |
| Stock Based Compensation | 1,233,000USD | 1,272,000USD | 3,091,000USD | 1,769,000USD | 1,108,000USD | 4,460,000USD | 3,276,000USD | 2,055,000USD |
| Deferred Income Tax | 400,000USD | — | — | — | 520,000USD | — | — | — |
| Change To Account Receivables | -2,250,000USD | 2,430,000USD | — | — | -2,095,000USD | — | — | — |
| Change To Inventory | -203,000USD | 199,000USD | — | — | 433,000USD | — | — | — |
| Change In Working Capital | -1,890,000USD | 999,000USD | — | — | -933,000USD | — | — | — |
| Operating Cash Flow | 970,000USD | — | 17,282,000USD | 8,789,000USD | 1,780,000USD | 20,459,000USD | 12,528,000USD | 2,686,000USD |
| Capital Expenditures | -157,000USD | -133,000USD | — | — | -131,000USD | — | — | — |
| Other Investing Activities | 577,000USD | — | — | — | 754,000USD | — | — | — |
| Unclassified Investing Cash Flow | -1,680,000USD | -2,785,000USD | — | — | -3,284,000USD | — | — | — |
| Investing Cash Flow | -1,260,000USD | — | -4,598,000USD | -4,346,000USD | -2,661,000USD | -13,239,000USD | -9,970,000USD | -7,114,000USD |
| Net Debt Issuance | -6,145,000USD | — | — | — | -14,407,000USD | — | — | — |
| Common Stock Issuance | 184,000USD | — | — | — | 159,000USD | — | — | — |
| Net Common Stock Issuance | -974,000USD | — | — | — | -3,123,000USD | — | — | — |
| Other Financing Activities | 6,145,000USD | — | — | — | 19,231,000USD | — | — | — |
| Financing Cash Flow | -790,000USD | — | -12,256,000USD | — | 1,860,000USD | -6,924,000USD | -2,409,000USD | 4,343,000USD |
| Change In Cash | -1,080,000USD | 2,231,000USD | 428,000USD | 193,000USD | 979,000USD | 296,000USD | 149,000USD | -85,000USD |
| End Cash Flow | 2,106,000USD | — | 955,000USD | 720,000USD | 1,506,000USD | 527,000USD | 380,000USD | 146,000USD |
| Net Income | — | 2,036,000USD | 2,259,000USD | 2,599,000USD | — | 933,000USD | 1,807,000USD | 717,000USD |
| Other Non Cash Items | — | -726,000USD | — | — | — | — | — | — |
| Total Cash From Operating Activities | — | 7,126,000USD | — | — | — | — | — | — |
| Free Cash Flow | — | 6,993,000USD | — | — | — | — | — | — |
| Total Cashflows From Investing Activities | — | -2,192,000USD | — | — | — | — | — | — |
| Net Borrowings | — | -1,360,000USD | — | — | — | — | — | — |
| Total Cash From Financing Activities | — | -2,703,000USD | — | — | — | — | — | — |
| Sale Purchase Of Stock | — | -1,375,000USD | — | — | — | — | — | — |
| Begin Period Cash Flow | — | 955,000USD | — | — | — | — | — | — |
| End Period Cash Flow | — | 3,186,000USD | — | — | — | — | — | — |
| Other Cashflows From Investing Activities | — | 726,000USD | — | — | — | — | — | — |
| Other Cashflows From Financing Activities | — | 33,000USD | — | — | — | — | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | DisclosurePreliminary | DisclosurePreliminary | DisclosureDeterministicFinal | DisclosurePreliminary | DisclosurePreliminary | DisclosurePreliminary |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Depreciation | 13,294,000USD | 12,499,000USD | 12,508,000USD | 13,360,000USD | 14,625,000USD | 14,025,000USD | 12,342,000USD | 11,308,000USD |
| Stock Based Compensation | 4,363,000USD | 4,460,000USD | 4,074,000USD | 3,825,000USD | 6,404,000USD | 2,610,000USD | 997,000USD | 957,000USD |
| Deferred Income Tax | 2,726,000USD | 1,918,000USD | 633,000USD | 19,000USD | -153,000USD | -10,071,000USD | 104,000USD | -62,000USD |
| Change To Account Receivables | 263,000USD | -701,000USD | -2,363,000USD | -1,153,000USD | 829,000USD | -2,631,000USD | -1,560,000USD | -4,413,000USD |
| Change To Inventory | 1,140,000USD | -126,000USD | -1,581,000USD | -882,000USD | -864,000USD | -102,000USD | -645,000USD | -490,000USD |
| Change In Working Capital | 1,517,000USD | 1,126,000USD | -6,742,000USD | -2,170,000USD | -196,000USD | -2,919,000USD | -2,334,000USD | -4,909,000USD |
| Operating Cash Flow | 24,408,000USD | 20,459,000USD | 11,223,000USD | 17,517,000USD | 18,316,000USD | 20,280,000USD | 13,875,000USD | 11,391,000USD |
| Capital Expenditures | -560,000USD | -1,092,000USD | -1,024,000USD | -982,000USD | -980,000USD | -1,094,000USD | -2,926,000USD | -281,000USD |
| Other Investing Activities | 3,308,000USD | 4,594,000USD | 4,383,000USD | 3,598,000USD | 3,317,000USD | 4,752,000USD | 2,952,000USD | 3,319,000USD |
| Unclassified Investing Cash Flow | -9,538,000USD | -16,741,000USD | -10,093,000USD | -14,094,000USD | -23,652,000USD | -15,820,000USD | -19,669,000USD | -8,022,000USD |
| Investing Cash Flow | -6,790,000USD | -13,239,000USD | -6,734,000USD | -11,478,000USD | -21,315,000USD | -12,162,000USD | -19,643,000USD | -4,984,000USD |
| Net Debt Issuance | -52,349,000USD | -56,113,000USD | -55,499,000USD | -42,035,000USD | -5,469,000USD | -37,180,000USD | -4,868,000USD | 4,843,000USD |
| Common Stock Issuance | 335,000USD | 387,000USD | 1,064,000USD | 1,355,000USD | 1,124,000USD | 190,000USD | 252,000USD | 91,000USD |
| Net Common Stock Issuance | -10,974,000USD | -1,996,000USD | -1,311,000USD | -6,652,000USD | -1,732,000USD | -1,714,000USD | -717,000USD | -10,465,000USD |
| Other Financing Activities | 48,226,000USD | 50,798,000USD | 51,552,000USD | 42,022,000USD | — | 37,587,000USD | 9,436,000USD | — |
| Unclassified Financing Cash Flow | -197,000USD | — | -229,000USD | -750,000USD | -386,000USD | — | -6,000USD | -27,000USD |
| Financing Cash Flow | -14,959,000USD | -6,924,000USD | -4,423,000USD | -6,060,000USD | -6,463,000USD | -1,117,000USD | 4,097,000USD | -5,558,000USD |
| Change In Cash | 2,659,000USD | 296,000USD | 66,000USD | -21,000USD | -9,462,000USD | 7,001,000USD | — | — |
| End Cash Flow | 3,186,000USD | 527,000USD | 231,000USD | 165,000USD | 186,000USD | 9,648,000USD | — | — |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal |
Cash flow YTD
| Metric | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q3 20232023-09-30 · USD | Q2 20232023-06-30 · USD | Q3 20222022-09-30 · USD | Q2 20222022-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Depreciation | 9,945,000USD | 6,661,000USD | 9,078,000USD | 5,933,000USD | 9,364,000USD | 6,296,000USD | 10,256,000USD | 6,816,000USD |
| Stock Based Compensation | 3,091,000USD | 1,769,000USD | 3,276,000USD | 2,055,000USD | 2,799,000USD | 1,736,000USD | 3,236,000USD | 2,170,000USD |
| Deferred Income Tax | 2,530,000USD | 1,363,000USD | 1,383,000USD | 405,000USD | 325,000USD | -106,000USD | -331,000USD | -435,000USD |
| Change To Account Receivables | -2,167,000USD | -2,089,000USD | -1,348,000USD | -1,203,000USD | -1,035,000USD | -506,000USD | -607,000USD | -924,000USD |
| Change To Inventory | 941,000USD | 863,000USD | -298,000USD | -437,000USD | -1,270,000USD | -885,000USD | -922,000USD | -937,000USD |
| Change In Working Capital | -198,000USD | -120,000USD | -509,000USD | -726,000USD | -4,609,000USD | -3,110,000USD | -1,618,000USD | -1,880,000USD |
| Operating Cash Flow | 17,282,000USD | 8,789,000USD | 12,528,000USD | 2,686,000USD | 6,565,000USD | 2,301,000USD | 12,951,000USD | 9,495,000USD |
| Capital Expenditures | -427,000USD | -348,000USD | -562,000USD | -519,000USD | -616,000USD | -494,000USD | -571,000USD | -336,000USD |
| Other Investing Activities | 1,170,000USD | 316,000USD | 2,754,000USD | 2,201,000USD | 3,429,000USD | 2,098,000USD | 2,597,000USD | 2,081,000USD |
| Unclassified Investing Cash Flow | -5,341,000USD | -4,314,000USD | -12,162,000USD | -8,796,000USD | -8,503,000USD | -6,994,000USD | -10,452,000USD | -6,669,000USD |
| Investing Cash Flow | -4,598,000USD | -4,346,000USD | -9,970,000USD | -7,114,000USD | -5,690,000USD | -5,390,000USD | -8,426,000USD | -4,924,000USD |
| Net Debt Issuance | -44,265,000USD | -30,261,000USD | -40,415,000USD | -26,744,000USD | -43,160,000USD | -29,451,000USD | -31,089,000USD | -20,665,000USD |
| Common Stock Issuance | 336,000USD | 159,000USD | 381,000USD | 225,000USD | 1,032,000USD | 829,000USD | 1,150,000USD | 746,000USD |
| Net Common Stock Issuance | -9,599,000USD | -6,853,000USD | -1,606,000USD | -907,000USD | -1,310,000USD | -676,000USD | -6,057,000USD | -4,995,000USD |
| Other Financing Activities | 41,502,000USD | 32,717,000USD | 39,231,000USD | 31,769,000USD | 42,788,000USD | 32,585,000USD | 32,398,000USD | 21,218,000USD |
| Unclassified Financing Cash Flow | -230,000USD | -12,000USD | — | — | -229,000USD | -229,000USD | -750,000USD | -750,000USD |
| Financing Cash Flow | -12,256,000USD | -4,250,000USD | -2,409,000USD | 4,343,000USD | -879,000USD | 3,058,000USD | -4,348,000USD | -4,446,000USD |
| Change In Cash | 428,000USD | 193,000USD | 149,000USD | -85,000USD | -4,000USD | -31,000USD | 177,000USD | 125,000USD |
| End Cash Flow | 955,000USD | 720,000USD | 380,000USD | 146,000USD | 161,000USD | 134,000USD | 363,000USD | 311,000USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Segment | Device Solutions | 6,460,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Segment | Other | 7,935,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Segment | Patient Services | 22,538,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Segment | Device Solutions | 6,276,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Segment | Other | 7,420,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Segment | Patient Services | 19,988,000 | USD | Disclosure |
| Q4 2025Quarterly · 2025-12-31 | Segment | Device Solutions | 8,999,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Other | 7,260,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Patient Services | 19,971,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Segment | Device Solutions | 34,893,000 | USD | Disclosure |
| FY 2025Yearly · 2025-12-31 | Segment | Other | 30,356,000 | USD | Disclosure |
| FY 2025Yearly · 2025-12-31 | Segment | Patient Services | 78,187,000 | USD | Disclosure |
| Q3 2025Quarterly · 2025-09-30 | Segment | Device Solutions | 8,742,000 | USD | Disclosure |
| Q3 2025Quarterly · 2025-09-30 | Segment | Other | 7,526,000 | USD | Disclosure |
| Q3 2025Quarterly · 2025-09-30 | Segment | Patient Services | 20,220,000 | USD | Disclosure |
| Q2 2025Quarterly · 2025-06-30 | Segment | Device Solutions | 8,945,000 | USD | Disclosure |
| Q2 2025Quarterly · 2025-06-30 | Segment | Other | 7,779,000 | USD | Disclosure |
| Q2 2025Quarterly · 2025-06-30 | Segment | Patient Services | 19,278,000 | USD | Disclosure |
| Q1 2025Quarterly · 2025-03-31 | Segment | Device Solutions | 8,207,000 | USD | Disclosure |
| Q1 2025Quarterly · 2025-03-31 | Segment | Other | 7,791,000 | USD | Disclosure |
| Q1 2025Quarterly · 2025-03-31 | Segment | Patient Services | 18,718,000 | USD | Disclosure |
| Q4 2024Quarterly · 2024-12-31 | Segment | Device Solutions | 7,317,000 | USD | Disclosure |
| Q4 2024Quarterly · 2024-12-31 | Segment | Other | 7,805,000 | USD | Disclosure |
| Q4 2024Quarterly · 2024-12-31 | Segment | Patient Services | 18,726,000 | USD | Disclosure |
| FY 2024Yearly · 2024-12-31 | Segment | Device Solutions | 33,495,000 | USD | Disclosure |
| FY 2024Yearly · 2024-12-31 | Segment | Other | 28,560,000 | USD | Disclosure |
| FY 2024Yearly · 2024-12-31 | Segment | Patient Services | 72,806,000 | USD | Disclosure |
| Q3 2024Quarterly · 2024-09-30 | Segment | Device Solutions | 9,147,000 | USD | Disclosure |
| Q3 2024Quarterly · 2024-09-30 | Segment | Other | 7,371,000 | USD | Disclosure |
| Q3 2024Quarterly · 2024-09-30 | Segment | Patient Services | 18,802,000 | USD | Disclosure |
| FY 2023Yearly · 2023-12-31 | Segment | Device Solutions | 30,759,000 | USD | Disclosure |
| FY 2023Yearly · 2023-12-31 | Segment | Other | 27,048,000 | USD | Disclosure |
| FY 2023Yearly · 2023-12-31 | Segment | Patient Services | 67,978,000 | USD | Disclosure |
| FY 2022Yearly · 2022-12-31 | Segment | Device Solutions | 22,426,000 | USD | Disclosure |
| FY 2022Yearly · 2022-12-31 | Segment | Other | 24,485,000 | USD | Disclosure |
| FY 2022Yearly · 2022-12-31 | Segment | Patient Services | 63,003,000 | USD | Disclosure |
| FY 2021Yearly · 2021-12-31 | Segment | Device Solutions | 20,014,000 | USD | Disclosure |
| FY 2021Yearly · 2021-12-31 | Segment | Other | 21,696,000 | USD | Disclosure |
| FY 2021Yearly · 2021-12-31 | Segment | Patient Services | 60,690,000 | USD | Disclosure |
| FY 2021Yearly · 2021-12-31 | Product | Direct Payer Rentals | 29,302,000 | USD | Disclosure |
| FY 2021Yearly · 2021-12-31 | Product | Product | 15,514,000 | USD | Disclosure |
| FY 2021Yearly · 2021-12-31 | Product | Services | 4,719,000 | USD | Disclosure |
| FY 2021Yearly · 2021-12-31 | Product | Third Party Payer Rental | 52,847,000 | USD | Disclosure |
| FY 2020Yearly · 2020-12-31 | Product | Direct Payer Rentals | 28,525,000 | USD | Disclosure |
| FY 2020Yearly · 2020-12-31 | Product | Product | 17,357,000 | USD | Disclosure |
| FY 2020Yearly · 2020-12-31 | Product | Services | 2,240,000 | USD | Disclosure |
| FY 2020Yearly · 2020-12-31 | Product | Third Party Payer Rental | 49,266,000 | USD | Disclosure |
| FY 2019Yearly · 2019-12-31 | Product | Direct Payer Rentals | 24,116,000 | USD | Disclosure |
| FY 2019Yearly · 2019-12-31 | Product | Product | 14,336,000 | USD | Disclosure |
| FY 2019Yearly · 2019-12-31 | Product | Services | 2,153,000 | USD | Disclosure |
| FY 2019Yearly · 2019-12-31 | Product | Third Party Payer Rental | 40,510,000 | USD | Disclosure |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.